Plasma Triglyceride Level and Mortality from Coronary Heart Disease

New England Journal of Medicine

Volumn 328, Issue 17, 1993, Pages 1220-1225

  Criqui, Michael H ^a   Heiss, Gerardo ^b   Cohn, Richard ^b   Cowan, Linda D ^c   Suchindran, Chirayath M ^b   Bangdiwala, Shrikant ^b   Kritchevsky, Steven ^d   Jacobs, David R ^e   O'grady, Haesook Kim ^b   Davis, C E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMAN; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MIDDLE AGE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; TRIGLYCERIDES;

EID: 0027410566     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199304293281702     Document Type: Article

References (47)

1. Hulley SB, Rosenman RH, Bawol RD, Brand RJ Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1980; 302:1383-1389
2. Nestel PJ Is serum triglyceride an independent predictor of coronary artery disease? Pract Cardiol 1987; 13:96-101
3. Austin MA Plasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond. Am J Epidemiol 1989; 129:249-259
4. Wilhelmsen L, Wedel H, Tibblin G Multivariate analysis of risk factors for coronary heart disease. Circulation 1973; 48:950-958
5. Salonen JT, Puska P Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population. Int J Epidemiol 1983; 12:26-31
6. Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR Is the level of serum triglyceride a significant predictor of coronary death in “normocholesterolemic” subjects? A Paris prospective study. Am J Epidemiol 1986; 124:624-632
7. Pocock SJ, Shaper AG, Phillips AN Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ 1989; 298:998-1002
8. Pelkonen R, Nikkila EA, Koskinen S, Penttinen K, Sarna S Association of serum lipids and obesity with cardiovascular mortality. BMJ 1977; 2:1185-1187
9. Glynn RJ, Rosner B, Silbert JE Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men. Circulation 1982; 66:724-731
10. Petersson B, Trell E, Hood B Premature death and associated risk factors in urban middle-aged men. Am J Med 1984; 77:418-426
11. Aberg H, Lithell H, Selinus I, Hedstrand H Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris: results from a ten-year follow-up of Uppsala primary preventive study. Atherosclerosis 1985; 54:89-97
12. Carlson LA, Bottiger LE Risk factors for ischaemic heart disease in men and women: results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985; 218:207-211
13. Lapidus L, Bengtsson C, Lindquist O, Sigurdsson JA, Rybo E Triglycerides – main lipid risk factor for cardiovascular disease in women? Acta Med Scand 1985; 217:481-489
14. Tverdal A, Foss OP, Leren P, Holme I, Lund-Larsen PG, Bjartveit K Serum triglycerides as an independent risk factor for death from coronary heart disease in middle-aged Norwegian men. Am J Epidemiol 1989; 129:458-465
15. Bainton D, Miller NE, Bolton CH, Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J 1992; 68:60-66
16. Cowan LD, Wilcosky T, Criqui MH, Demographic, behavioral, biochemical, and dietary correlates of plasma triglycerides: the Lipid Research Clinics Program Prevalence Study. Arteriosclerosis 1985; 5:466-480
17. Jacobs DR Jr, Barrett-Connor E Retest reliability of plasma cholesterol and triglyceride: the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1982; 116:878-885
18. Davis CE, Gordon D, LaRosa J, Wood PD, Halperin M Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations. Circulation 1980; 62: Suppl IV: IV-24
19. 2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80:341-347
20. Heyden S, Heiss G, Hames G, Bartel AG Fasting triglycerides as predictors of total and CHD mortality in Evans County, Georgia. J Chronic Dis 1980; 33:275-282
21. Castelli WP The triglyceride issue: a view from Framingham. Am Heart J 1986; 112:432-437
22. West KM, Ahuja MMS, Bennett PH, The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6:361-369
23. Janka HU Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metab Res Suppl 1985; 15:15-19
24. Fontbonne A, Eschwege E, Cambien F, Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32:300-304
25. Criqui MH, Cowan LD, Tyroler HA, Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the Lipid Research Clinics Follow-up Study. Am J Epidemiol 1987; 126:629-637
26. Williams OD, Stinnett S, Chambless LE, Populations and methods for assessing dyslipoproteinemia and its correlates: the Lipid Research Clinics Program Prevalence Study. Circulation 1986; 73: Suppl I: I-4
27. Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Lipid and lipoproteins. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75-628).
28. Criqui MH, Cowan LD, Heiss G, Haskell WL, Laskarzewski PM, Chambless LE Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia: the Lipid Research Clinics Program Prevalence Study. Circulation 1986; 73: Suppl I: I-40
29. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the Follow-up Study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131:32-47
30. LaRosa JC, Chambless LE, Criqui MH, Patterns of dyslipoproteinemia in selected North American populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1986; 73: Suppl I: I-12
31. Cox DR Regression models and life-tables. J R Stat Soc [B] 1972; 34:187-220
32. Criqui MH Triglyceride: a risk factor? Prog Cardiol 1990; 3:3-10
33. Davis CE, Kim H Is triglyceride level an independent risk factor for CHD? Circulation 1990; 81:725-725 abstract.
34. Abbott RD, Wilson PWF, Kannel WB, Castelli WP High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham Study. Arteriosclerosis 1988; 8:207-211
35. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991; 325:373-381
36. Benfante RJ, Reed DM, MacLean CJ, Yano K Risk factors in middle age that predict early and late onset of coronary heart disease. J Clin Epidemiol 1989; 42:95-104
37. Assmann G, Schulte H Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992; 70:733-737
38. Manninen V, Tenkanen L, Koskinen P, Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992; 85:37-45
39. Avins AL, Hulley SB Joint effects of serum triglycerides and LDL and HDL cholesterol. Circulation 1993; 87:300-301
40. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325:1196-1204
41. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260:1917-1921
42. Lamon-Fava S, McNamara JR, Farber H, Hill N, Schaefer EJ Changes in lipids, apolipoproteins, and low density lipoprotein particle size after prolonged strenuous physical exercise. Clin Res 1988; 36:787A-787A abstract.
43. Wu LL, Hunt SC, Afman G, Genetic concordance of and exercise effects on low density lipoprotein subfractions in Utah twins. Circulation 1988; 78: Suppl II: II-481 abstract.
44. Carlson LA, Rosenhamer G Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988; 223:405-418
45. Simpson HCR, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L Hypertriglyceridaemia and hypercoagulability. Lancet 1983; 1:786-790
46. Hamsten A, Wiman B, de Faire U, Blomback M Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313:1557-1563
47. Hamsten A, de Faire U, Walldius G, Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 2:3-9